Fittingly, overexpression of GNL3 was previously shown to reduce the density of mushroom dendritic spines in rats, which might relate to dendritic spine pathology observed across patients with schizophrenia, bipolar disorder, and depression [45]. Here, GNL3 is linked to depressive disorder.